Reach Resources Limited (ASX: RR1) December 2024 Quarterly Activities Report
Reach Resources (ASX: RR1) reveals strong gold and REE potential in December 2024 quarterly activities report.
Neurizon Therapeutics Limited (ASX: NUZ) Investigational New Drug Application Update
Neurizon Therapeutics Limited announces FDA has placed its NUZ-001 IND application under clinical hold, seeking further information.
Adriatic Metals PLC (ASX:ADT) Finalises Prepayment Agreement
Adriatic Metals PLC executes a US$25M prepayment agreement with Trafigura, enhancing its cash position.
Archer Materials (ASX:AXE) Reports Debt-Free Q2 FY25 Activities and Financials
Archer Materials (ASX:AXE) reports progress in quantum projects and TMR sensor technology with a strong cash position in Q2 FY25.
Singular Health Group (ASX:SHG) Advances Remote Medical Imaging Initiative
Singular Health (ASX: SHG) confirms successful Phase 1 completion with PNS, advancing to Phase 2 in its medical imaging project.
Marquee Resources Limited (ASX:MQR) Completes Successful Capital Raising
Marquee Resources Limited (ASX:MQR) raises $829,153 through a successful oversubscribed share placement, signifying strong investor confidence.
Global Uranium and Enrichment Limited (ASX:GUE) Secures $1.8 Million Placement
Global Uranium and Enrichment Limited raises $1.8 million through a share placement to support its uranium project portfolio.
GTI Energy Ltd (ASX:GTR) Begins Drilling at Lo Herma ISR Uranium Project
GTI Energy Ltd (ASX:GTR) has commenced drilling at the Lo Herma ISR Uranium Project, with key tests and studies ongoing to support future operations.
Critica Limited (ASX:CRI) Releases Mining Bond, Boosts Jupiter Project
Critica Limited announces the release of a mining bond, strengthening its position for advancements in the Jupiter Rare Earths Project.
Lynas Rare Earths Ltd (ASX:LYC) Reports Strong Q2 FY25 Results
Lynas Rare Earths Ltd (ASX:LYC) announces significant revenue growth and operational advancements for Q2 FY25 despite market challenges.